Sassine

Exicure Announces Appointments of Elizabeth Garofalo, M.D., and Andrew Sassine to Its Board of Directors

Retrieved on: 
Tuesday, March 9, 2021
Biotechnology, Pharmaceutical, Genetics, Health, Articles, Arcturus Therapeutics, Sassine, Board of directors, Business

and Mr. Andrew Sassine to its Board of Directors.

Key Points: 
  • and Mr. Andrew Sassine to its Board of Directors.
  • Dr. Garofalo is a biopharma executive with more than 25 years of experience in global clinical development and regulatory affairs.
  • Andrew Sassine currently serves as Chief Financial Officer and member of the board of directors of Arcturus Therapeutics.
  • I am excited to join the Exicure team and its distinguished Board of Directors, said Andrew Sassine.

Synopsys Appoints Sassine Ghazi as Chief Operating Officer

Retrieved on: 
Wednesday, August 19, 2020
Hillsboro, Oregon, Synopsys, Sassine, Electronic design automation, Companies, Computer engineering

MOUNTAIN VIEW, Calif., Aug. 19, 2020 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced that Sassine Ghazi has been appointed as Chief Operating Officer.

Key Points: 
  • MOUNTAIN VIEW, Calif., Aug. 19, 2020 /PRNewswire/ -- Synopsys, Inc. (Nasdaq: SNPS) today announced that Sassine Ghazi has been appointed as Chief Operating Officer.
  • Ghazi, who joined Synopsys in 1998, brings multiple decades of experience in chip design, applications engineering, customer support, sales, and business management.
  • "It is a privilege to assume the COO position, working alongside our senior leaders to further evolve and focus the strengths of Synopsys," said Sassine Ghazi.
  • "Synopsys is a strong company powered by industry leaders, an outstanding field organization and committed employees," added Chi-Foon Chan, co-CEO of Synopsys.